跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BILASTINA VIVANTA 20 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BILASTINA VIVANTA 20 MG COMPRIMIDOS EFG
Approved
STANDARD
BILASTINA VIVANTA 20 MG COMPRIMIDOS EFG
Vivanta Generics S.R.O.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 19, 2022
Approval ID
2e160b1a2b49d69f
Company
Vivanta Generics S.R.O.
Type
Standard
Approval Details
Approval Id
2e160b1a2b49d69f
Drug Cima Aemps Name
BILASTINA VIVANTA 20 MG COMPRIMIDOS EFG
Register Number
87324
Holder Company Name
Vivanta Generics S.R.O.
Marketing Company Name
Mabo Farma S.A.
Authorization Date
2022-05-19
Dosage Form
COMPRIMIDO
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Vivanta Generics S.R.O.
Active Ingredients
BILASTINA
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 19, 2022
Approval ID
2e160b1a2b49d69f
Type
Standard
Back to CIMA-AEMPS Approvals